Literature DB >> 15505780

A clinical trial of bromocriptine for treatment of primary progressive aphasia.

Deborah A Reed, Nancy A Johnson, Cynthia Thompson, Sandra Weintraub, M-Marsel Mesulam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15505780     DOI： 10.1002/ana.20301

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  19 in total

Review 1.  Treatment approaches to symptoms associated with frontotemporal degeneration.

Authors:  Tiffany W Chow
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 2.  An update on primary progressive aphasia.

Authors:  Emily Rogalski; Marsel Mesulam
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 3.  Quantitating severity and progression in primary progressive aphasia.

Authors:  Bradford C Dickerson
Journal:  J Mol Neurosci       Date:  2011-05-15       Impact factor: 3.444

Review 4.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

5.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

6.  Psycholinguistics of Aphasia Pharmacotherapy: Asking the Right Questions.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Abigail Oveis
Journal:  Aphasiology       Date:  2014-01-01       Impact factor: 2.773

7.  Pilot trial of memantine in primary progressive aphasia.

Authors:  Nancy A Johnson; Alfred Rademaker; Sandra Weintraub; Darren Gitelman; Christina Wienecke; Marsel Mesulam
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

8.  Frontotemporal dementia and primary progressive aphasia: an update.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

Review 9.  [Chronic progressive aphasia].

Authors:  J Diehl-Schmid; C Knels; A Danek
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

Review 10.  Development of disease-modifying drugs for frontotemporal dementia spectrum disorders.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Davide Seripa; Antonio Daniele; Mark Watling; Gianluigi Giannelli
Journal:  Nat Rev Neurol       Date:  2020-03-23       Impact factor: 42.937
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.